Intrinsic value of Intercept Pharmaceuticals, Inc. (ICPT)

[per Chepakovich valuation model]

other valuations of ICPT

[per Chepakovich valuation model]  See other valuations of ICPT stock

Previous Close$16.90
Intrinsic Value
Upside potential
Previous Close
$16.90

VALUATION INPUT DATA

Revenue, mln $
Initial revenue growth rate (norm.), %
Variable cost ratio, %
Fixed operating expenses, mln $
Production assets / Revenue, %
Working capital / Revenue, %
Interest rate on debt, %
Life of production assets, yrs
Initial discount rate, %
Shares outstanding, mln
Adjusted equity ratio
Adjusted assets / Revenue
Based on fiscal year data as of 2020-12-31 and quarterly data as of 2021-03-31.
NOTE: The bar chart shows historic and forecasted yearly revenue growth rates. Its purpose is to help you in determining what initial revenue rate you want to base your stock valuation on. Please make sure that you are confident in the value you select - for most stocks it is by far the most important parameter in valuation.
  1. Annual
  2. Quarterly YoY
  3. Quarterly QoQ

Annual revenue growth rates, % (past and forecasted)

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year2020(a)2021202220232024202520262027202820292030203120322033203420352036203720382039204020412042204320442045

INCOME STATEMENT

Revenue growth rate, %24.1NaN
Revenue, $313NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $m544NaN
Operating income, $m-231NaN
EBITDA, $m-196NaN
Interest expense (income), $mNaN
Earnings before tax, $m-277NaN
Tax expense, $m-2NaN
Net income, $m-275NaN

BALANCE SHEET

Cash and short-term investments, $m477NaN
Total assets, $m580NaN
Adjusted assets (=assets-cash), $m103NaN
Average production assets, $m156NaN
Working capital, $m367NaN
Total debt, $m561NaN
Total liabilities, $m747NaN
Total equity, $m-167NaN
Debt-to-equity ratio-3.360NaN
Adjusted equity ratio-6.233NaN

CASH FLOW

Net income, $m-275NaN
Depreciation, amort., depletion, $m36NaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $m-170NaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $m-4NaN
Free cash flow, $m-166NaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $m367
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN